Tarik Möröy, a researcher at the Montreal Clinical Research Institute (IRCM), was elected as a Fellow of the Canadian Academy of Health Sciences. The Academy recognizes researchers’ exemplary contributions in health sciences, as well as the quality and innovation of their discoveries, and their leadership.
Dr. Möröy is the Director of the IRCM Hematopoiesis and Cancer Research Unit. He is the Institute’s President and Scientific Director since 2006, a Full Research Professor at Université de Montréal, and an adjunct professor at McGill University. He holds the Canada Research Chair in Hematopoiesis and Immune Cell Differentiation. He also serves on the boards of directors of the Canadian Society for Molecular Biosciences and Research Canada. Dr. Möröy’s research aims to advance the understanding of the molecular basis of physiology, ontogenesis, and the differentiation of blood cells, and to reveal the mechanisms leading to cancer in the hematopoietic system, such as leukemia and lymphoma.